Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 16:18:43-53.
doi: 10.2147/VHRM.S343319. eCollection 2022.

Cardiovascular Disease-Associated Skin Conditions

Lia Hojman  1 , Claudio Karsulovic  2
Affiliations
Review

Cardiovascular Disease-Associated Skin Conditions

Lia Hojman et al. Vasc Health Risk Manag. .

Abstract

According to data from the American Heart Association and the World Health Organization, cardiovascular disease (CVD) is the most frequent cause of premature death. Several inflammatory and non-inflammatory skin diseases have been associated with metabolic syndrome and cardiovascular risk (CVR). Here, we classified these conditions into traditionally CVR-associated and those that have been linked to a lesser degree. Psoriasis and hidradenitis suppurativa are commonly associated with CVD, sharing common inflammatory pathways and a higher prevalence of traditional cardiovascular risk factors. Many other diseases could be associated indirectly - with no common pathogenic features with the atheromatous disease - but share a higher prevalence of standard cardiovascular risk and chronic inflammatory state. This review aims to highlight the associated cardiovascular risk that exists for some dermatologic diseases and sensitize cardiologists, dermatologists, and first care providers to implement risk factor control promptly.

Keywords: atheromatosis; cardiovascular disease; cardiovascular risk; skin diseases.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

References

    1. Perk J. The 2016 version of the European Guidelines on Cardiovascular Prevention. Eur Heart J Cardiovasc Pharmacother. 2017;3(1):9–10. doi:10.1093/ehjcvp/pvw030 - DOI - PubMed
    1. Durga J, Verhoef P, Bots ML, Schouten E. Homocysteine and carotid intima-media thickness: a critical appraisal of the evidence. Atherosclerosis. 2004;176(1):1–19. doi:10.1016/j.atherosclerosis.2003.11.022 - DOI - PubMed
    1. Hansildaar R, Vedder D, Baniaamam M, Tausche AK, Gerritsen M, Nurmohamed MT. Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout. Lancet Rheumatol. 2020;3:e58–e70. doi:10.1016/S2665-9913(20)30221-6 - DOI - PMC - PubMed
    1. Piranavan P, Perl A. Management of cardiovascular disease in patients with systemic lupus erythematosus. Expert Opin Pharmacother. 2020;21(13):1617–1628. doi:10.1080/14656566.2020.1770227 - DOI - PMC - PubMed
    1. Bulger DA, Minhas S, Asbeutah AA, et al. Chronic systemic inflammatory skin disease as a risk factor for cardiovascular disease. Curr Probl Cardiol. 2021;46(5):100799. doi:10.1016/j.cpcardiol.2021.100799 - DOI - PubMed

MeSH terms